$AAVL - Phase 1 36-month follow-up data demonstrates continued safety and tolerability; rescue injections averaged less than one per year
<ticker> - phase <number> <number> - month follow - up data demonstrates continued safety and tolerability ; rescue injections averaged less than one per year